Bicara Therapeutics Inc (NAS:BCAX)
$ 29.34 +2.47 (+9.19%) Market Cap: 1.93 Bil Enterprise Value: 1.39 Bil PE Ratio: 0 PB Ratio: 3.74 GF Score: 12/100

Bicara Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 04:20 PM GMT
Release Date Price: $20.99 (-6.21%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BCAX.OQ - Bicara Therapeutics Inc
Bicara Therapeutics Inc at Bank of America Global Healthcare Conference
May 13, 2026 / 04:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everybody. Welcome back to the Bank of America Healthcare Conference. I'm Tazeen Ahmad, one of the senior biotech analysts here at the Bank. It is my pleasure to have our next presenting company, Bycara Therapeutics. Up here on stage with me is Ryan Kohlhaupt from Bycara. Ryan, good morning.

Thank you for making the trip over from Boston.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you.

Thank you for having us and, appreciate the opportunity to.

Here today.

-------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot